SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-23-000171
Filing Date
2023-01-04
Accepted
2023-01-03 19:18:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 424279
2 form424b5_001.jpg GRAPHIC 3230
3 forms-3_001.jpg GRAPHIC 2079
  Complete submission text file 0001493152-23-000171.txt   433115
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267870 | Film No.: 23503930
SIC: 2834 Pharmaceutical Preparations